MHF | NZF | MHF / NZF | |
Gain YTD | 8.315 | 2.582 | 322% |
Net Assets | 149M | 2.41B | 6% |
Total Expense Ratio | 0.70 | 1.60 | 44% |
Turnover | 20.00 | 16.00 | 125% |
Yield | 4.59 | 6.01 | 76% |
Fund Existence | 37 years | 24 years | - |
MHF | NZF | |
---|---|---|
RSI ODDS (%) | 4 days ago82% | 4 days ago50% |
Stochastic ODDS (%) | 4 days ago72% | 4 days ago66% |
Momentum ODDS (%) | 4 days ago87% | 4 days ago72% |
MACD ODDS (%) | 4 days ago80% | 4 days ago73% |
TrendWeek ODDS (%) | 4 days ago83% | 4 days ago75% |
TrendMonth ODDS (%) | 4 days ago83% | 4 days ago74% |
Advances ODDS (%) | 4 days ago84% | 5 days ago76% |
Declines ODDS (%) | 10 days ago75% | 21 days ago79% |
BollingerBands ODDS (%) | 4 days ago69% | 4 days ago65% |
Aroon ODDS (%) | 4 days ago76% | 4 days ago74% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ETHD | 13.29 | 0.26 | +2.00% |
Proshares UltraShort Ether ETF | |||
RSPS | 30.60 | 0.08 | +0.25% |
Invesco S&P 500® Eql Wt Cnsm Stapl ETF | |||
CXH | 7.62 | 0.01 | +0.13% |
MFS Investment Grade Municipal Trust | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
YINN | 39.39 | -1.35 | -3.31% |
Direxion Daily FTSE China Bull 3X ETF |